| 2024-01-03 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, Chief Financial Officer | 5,365 0.006% | $29.46 | $158,053 | -12.78% | |
| 2023-01-04 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, Chief Financial Officer | 2,427 0.0026% | $37.21 | $90,309 | -3.48% | |
| 2022-01-01 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, Chief Financial Officer | 1,013 0.0013% | $112.24 | $113,699 | ||
| 2021-09-07 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, Chief Financial Officer | 3,482 0.0052% | $180.12 | $627,178 | -55.09% | |
| 2021-08-31 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, Chief Financial Officer | 24,800 0.0336% | $160.22 | $3.97M | -51.39% | |
| 2021-08-30 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, Chief Financial Officer | 5,200 0.0071% | $155.78 | $810,082 | -48.07% | |
| 2021-08-05 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, Chief Financial Officer | 20,000 0.0248% | $151.05 | $3.02M | -44.97% |